The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America, E-Book

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology, Oncology
Cover of the book The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America, E-Book by Ann Mullally, MD, Elsevier Health Sciences
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Ann Mullally, MD ISBN: 9780323532365
Publisher: Elsevier Health Sciences Publication: July 14, 2017
Imprint: Elsevier Language: English
Author: Ann Mullally, MD
ISBN: 9780323532365
Publisher: Elsevier Health Sciences
Publication: July 14, 2017
Imprint: Elsevier
Language: English

This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!

More books from Elsevier Health Sciences

Cover of the book Contribution of FDG to Modern Medicine, Part I, An Issue of PET Clinics, E-Book by Ann Mullally, MD
Cover of the book Geriatric Oncology, An Issue of Clinics in Geriatric Medicine by Ann Mullally, MD
Cover of the book Psychopathologie du travail by Ann Mullally, MD
Cover of the book Acute Care Handbook for Physical Therapists - E-Book by Ann Mullally, MD
Cover of the book Practical Guide to Neurogenetics by Ann Mullally, MD
Cover of the book Hepatitis C Infection as a Systemic Disease:Extra-HepaticManifestation of Hepatitis C, An Issue of Clinics in Liver Disease, E-Book by Ann Mullally, MD
Cover of the book Kumar and Clark's Clinical Medicine E-Book by Ann Mullally, MD
Cover of the book Optimizing the Treatment of Upper Extremity Injuries in Athletes, An Issue of Hand Clinics, E-Book by Ann Mullally, MD
Cover of the book Elsevier's Veterinary Assisting Textbook - E-Book by Ann Mullally, MD
Cover of the book Schizophrenia: Advances and Current Management, An Issue of Psychiatric Clinics of North America, E-Book by Ann Mullally, MD
Cover of the book Cardiovascular Therapeutics E-Book by Ann Mullally, MD
Cover of the book Adolescent Health & Development by Ann Mullally, MD
Cover of the book vol 3: Skin, Superficial Fascia, and Deep Fascia of the Neck by Ann Mullally, MD
Cover of the book Crash Course Rheumatology and Orthopaedics by Ann Mullally, MD
Cover of the book Advanced Epidemiologic Methods for the Study of Rheumatic Diseases, An Issue of Rheumatic Disease Clinics of North America, E-Book by Ann Mullally, MD
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy